Pages that link to "Q40839188"
Jump to navigation
Jump to search
The following pages link to Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. (Q40839188):
Displaying 50 items.
- VEGF-Trap: a VEGF blocker with potent antitumor effects (Q24535043) (← links)
- Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy (Q24655930) (← links)
- New advances in targeted gastric cancer treatment (Q26738548) (← links)
- Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas (Q26825000) (← links)
- The role of vascular endothelial growth factor a polymorphisms in breast cancer (Q26851522) (← links)
- Receptor tyrosine kinase-mediated angiogenesis (Q27001612) (← links)
- A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models (Q28749085) (← links)
- Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study (Q30155518) (← links)
- Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism. (Q30450365) (← links)
- Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. (Q33187344) (← links)
- Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies (Q33586368) (← links)
- Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers (Q33625077) (← links)
- Vascular endothelial growth factor signaling in hypoxia and inflammation (Q33721685) (← links)
- The VEGF family in cancer and antibody-based strategies for their inhibition (Q33733437) (← links)
- Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2 (Q33733451) (← links)
- Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis (Q33750051) (← links)
- Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis (Q33846832) (← links)
- Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60. (Q33858304) (← links)
- Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma (Q33867266) (← links)
- Ablation of lung epithelial cells deregulates FGF-10 expression and impairs lung branching morphogenesis (Q34034390) (← links)
- VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells (Q34053767) (← links)
- RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells (Q34072657) (← links)
- Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer. (Q34343963) (← links)
- Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody (Q34455259) (← links)
- Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma (Q34786374) (← links)
- Characteristics of human Ewing/PNET sarcoma models (Q35008659) (← links)
- Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC (Q35050210) (← links)
- Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume. (Q35068630) (← links)
- Regression of established tumors and metastases by potent vascular endothelial growth factor blockade (Q35146833) (← links)
- Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade (Q35178731) (← links)
- Angiogenic growth factor responses to long-term treadmill exercise in mice (Q35588494) (← links)
- Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. (Q35599819) (← links)
- Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies (Q35652113) (← links)
- Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis (Q35782469) (← links)
- Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc /min mice (Q35836870) (← links)
- Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha (Q35847620) (← links)
- Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy (Q35918945) (← links)
- Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer (Q35954103) (← links)
- Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy (Q36089148) (← links)
- Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma (Q36397210) (← links)
- Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours (Q36694450) (← links)
- Improved biological activity of a mutant endostatin containing a single amino-acid substitution (Q36694928) (← links)
- A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site (Q36762954) (← links)
- The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion (Q36907325) (← links)
- The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues (Q36994025) (← links)
- Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis (Q37319742) (← links)
- Molecular mechanisms of endothelial hyperpermeability: implications in inflammation (Q37535022) (← links)
- Endothelial contractile cytoskeleton and microvascular permeability (Q37792813) (← links)
- Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma (Q37831148) (← links)
- Current State-of-the-Art Systemic Therapy for Pediatric Soft Tissue Sarcomas (Q38005629) (← links)